Skip to content

NUVB

Nuvation Bio Inc.

NYSE · Healthcare · Biotechnology · US

$5.85
−3.62%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 2, 2026
EPS estimate
-$0.12
Revenue estimate
$35.3M

Latest reported

Last report date
Aug 6, 2026
EPS actual
-$0.15
EPS estimate
-$0.14
Revenue actual
$31.7M
Revenue estimate
$27.0M

Track record

Trailing twelve quarters

EPS beats (12Q)
4
EPS misses (12Q)
5
EPS in line (12Q)
3
Avg surprise (4Q)
-24.4%
Revenue beats (12Q)
5

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$15
PT range
$10 – $21
Analysts
8
8 Buy0 Hold0 Sell
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 6, 2026-$0.14-$0.15Miss -5.89%$31.7M
May 4, 2026$0.12$0.01Miss -91.67%$83.2M
Aug 7, 2025-$0.17-$0.17In line$4.8M
May 7, 2025-$0.16-$0.16In line$3.1M
Mar 6, 2025-$0.14-$0.15Miss -7.14%$5.7M
Feb 29, 2024-$0.10-$0.06Beat 40.00%$264.0K
Nov 2, 2023-$0.10-$0.09Beat 10.00%
Aug 3, 2023-$0.11-$0.09Beat 18.18%
May 4, 2023-$0.09-$0.10Miss -11.11%
Mar 15, 2023-$0.10-$0.10In line
Nov 3, 2022-$0.14-$0.12Beat 14.29%
Aug 4, 2022-$0.13-$0.16Miss -23.08%

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 2, 2026